Botox® injections improve appearance by relaxing muscles that cause wrinkles. These injections also treat medical conditions, including migraines, hyperhidrosis, overactive bladder and eye problems. To maintain results, treatments should be repeated every three to six months.
Kybella is the first FDA approved treatment to help contour and improve the appearance. of submental fullness or a “double chin.” It is an injection into the subcutaneous fat. It destroys fat cells, making them unable to sore or accumulate fat.
Juvederm Ultra Plus is an ideal hyaluronic acid dermal filler that is designed to correct age-related volume loss, diminish the appearance of fine lines, deep facial wrinkles, and provide the perfect lip augmentation.
Volbella is a Juvederm dermal filler designed to plump and augment the lips. It is FDA-approved to not only add volume to the lips but to smooth lines and wrinkles around the mouth that often result from sun damage, lifestyle factors, and the aging process.
Juvederm Vollure is a hyaluronic acid dermal filler that is injected into the skin to correct age-related lines and wrinkles and improve facial volume in any treatment area. Juvederm Vollure, like the Juvederm family of dermal fillers, is composed of hyaluronic acid.
The first and only FDA-approved dermal filler designed specifically to lift sunken facial skin. This injectable treatment instantly adds volume to the cheek area that has lost volume over the years. The result is a rejuvenated, youthful plumpness.
SKINVIVE™ by JUVÉDERM® is the first and only FDA-approved hyaluronic acid (HA) microdroplet injectable in the US to improve skin smoothness of the cheeks. This product increases hydration to improve skin smoothness and provide a lasting glow for up to 6 months with optimal treatment. Also, in a clinical study, patients treated with SKINVIVE™ reported higher satisfaction with how glowing, hydrated, refreshed, and healthy their skin looked*.
© Copyright 2023 Serene Aesthetics & Med Spa. All Rights Reserved.
Website Developed by Raincross.